A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

NCT03384966 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

346

Enrollment

INDUSTRY

Sponsor class

Conditions

Stable Coronary Artery Disease

Interventions

DRUG: Selatogrel
DRUG: Placebo
DRUG: Selatogrel

Sponsor

Viatris Innovation GmbH